CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shengtai Pharmaceutical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shengtai Pharmaceutical Inc
Changda Road East
Development District, Changle County
Phone: +86 5362182777p:+86 5362182777 WEIFANG, SDG  262400  China Ticker: SGTI SGTI
This company ceased filing statements with the SEC on 8/30/2013.
Business Summary
Shengtai Pharmaceutical, Inc. (Shengtai), through its wholly owned subsidiary, Weifang Shengtai Pharmaceutical Inc., is a producer of pharmaceutical-grade glucose in China. The Company's products include pharmaceutical-grade glucose or dextrose, used for medical purposes, as well as other glucose and cornstarch products used for the food and beverage industry, and for industrial productions in China. The Company's glucose series include dextrose monohydrate (DMH), dextrose anhydrous, oral glucose dextrin and rough glucose for other processing purposes. Its starch series include pharmaceutical starch and edible corn starch. The Company's customers include healthcare institutions, food and beverage companies, pharmaceutical companies, medical supply exporters and medical supply. The Company also exports its products to approximately 70 different countries overseas, such as Japan, Singapore, Korea, Australia, Russia and India.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20136/30/2012YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
5500 Automotive dealers and gasoline service stations
2046 Wet corn milling

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer QingtaiLiu 55 1/1/2011 5/15/2007
Chief Financial Officer, Director YongqiangWang 43 12/1/2010 5/15/2007
Independent Director TaoJin 46 11/1/2011 11/1/2011
Independent Director LawrenceLee 57 2/13/2012 2/13/2012
Independent Director YaojunLiu 36 6/1/2010 6/1/2010

Business Names
Business Name
SGTI
Shengtai Holding Inc.
Shengtai Pharmaceutical Inc.
Weifang Shengtai Pharmaceutical Co., Ltd.
West Coast Car Company

General Information
Number of Employees: 733 (As of 6/30/2012)
Outstanding Shares: 9,584,912 (As of 5/15/2013)
Stock Exchange: OTC
Federal Tax Id: 542155579


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023